{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:19:03Z","timestamp":1781317143304,"version":"3.54.1"},"reference-count":81,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1136\/bjophthalmol-2015-307955","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T04:03:45Z","timestamp":1452225825000},"page":"731-735","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Corticosteroids as a therapy for bacterial keratitis: an evidence-based review of \u2018who, when and why\u2019"],"prefix":"10.1136","volume":"100","author":[{"given":"Raghad T","family":"Tallab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald U","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-307955-1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ceo.12330","article-title":"Corneal blindness: a global problem","volume":"42","author":"Robaei","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-3","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/bjophthalmol-2015-307955-4","doi-asserted-by":"crossref","first-page":"181564","DOI":"10.1155\/2013\/181564","article-title":"Spectrum of bacterial keratitis at a tertiary eye care centre in India","volume":"2013","author":"Kaliamurthy","year":"2013","journal-title":"Biomed Res Int"},{"key":"key-10.1136\/bjophthalmol-2015-307955-5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bjo.87.7.805","article-title":"Microbial keratitis","volume":"87","author":"Jeng","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":"Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases","volume":"87","author":"Bourcier","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/bjo.72.12.926","article-title":"Predisposing factors in microbial keratitis: the significance of contact lens wear","volume":"72","author":"Dart","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12126","article-title":"Mycotic keratitis: epidemiology, diagnosis and management","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307955-9","first-page":"175","article-title":"Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century","volume":"24","author":"Forster","year":"1998","journal-title":"CLAO J"},{"key":"key-10.1136\/bjophthalmol-2015-307955-10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.2009.169607","article-title":"Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature","volume":"95","author":"Shah","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/bjo.35.11.637","article-title":"The clinical value of cortisone and ACTH in ocular disease; a preliminary assessment for the Medical Research Council","volume":"35","author":"Duke-Elder","year":"1951","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-12","first-page":"64","article-title":"Cortisone and hydrocortisone in ocular infections","volume":"57","author":"Thygeson","year":"1953","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0161-6420(02)00963-6","article-title":"Indecision about corticosteroids for bacterial keratitis: an evidence-based update","volume":"109","author":"Wilhelmus","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archophthalmol.2008.504","article-title":"Rationale for adjunctive topical corticosteroids in bacterial keratitis","volume":"127","author":"Hindman","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archophthalmol.2008.503","article-title":"The case against the use of steroids in the treatment of bacterial keratitis","volume":"127","author":"Cohen","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1515\/BC.2004.131","article-title":"Role of bacterial proteases in pseudomonal and serratial keratitis","volume":"385","author":"Matsumoto","year":"2004","journal-title":"Biol Chem"},{"key":"key-10.1136\/bjophthalmol-2015-307955-17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1444-0938.2002.tb03082.x","article-title":"The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa","volume":"85","author":"Fleiszig","year":"2002","journal-title":"Clin Exp Optom"},{"key":"key-10.1136\/bjophthalmol-2015-307955-18","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/IAI.62.6.2478-2482.1994","article-title":"Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis","volume":"62","author":"Callegan","year":"1994","journal-title":"Infect Immun"},{"key":"key-10.1136\/bjophthalmol-2015-307955-19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mayocp.2014.09.006","article-title":"Non-anti-infective effects of antimicrobials and their clinical applications: a review","volume":"90","author":"Sadarangani","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"key-10.1136\/bjophthalmol-2015-307955-20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2003.10.002","article-title":"Corneal response to Pseudomonas aeruginosa infection","volume":"23","author":"Hazlett","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-307955-21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/09273940490912362","article-title":"Role of innate and adaptive immunity in the pathogenesis of keratitis","volume":"13","author":"Hazlett","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"key-10.1136\/bjophthalmol-2015-307955-22","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/01.ico.0000178737.35297.d4","article-title":"Role of cytokines and chemokines in pseudomonal keratitis","volume":"24","author":"Matsumoto","year":"2005","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307955-23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles Prize Lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V62.5.1070.1070","article-title":"The mechanism of action of the antiinflammatory agents dexamethasone and Auranofin in human polymorphonuclear leukocytes","volume":"62","author":"Coates","year":"1983","journal-title":"Blood"},{"key":"key-10.1136\/bjophthalmol-2015-307955-25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.2002.tb04208.x","article-title":"Regulation of leukocyte-endothelial interactions by glucocorticoids","volume":"966","author":"Pitzalis","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key-10.1136\/bjophthalmol-2015-307955-27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","article-title":"Tetracyclines and the treatment of corneal stromal ulceration: a review","volume":"19","author":"Ralph","year":"2000","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307955-28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ophtha.2014.01.011","article-title":"Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting","volume":"121","author":"Said","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-29","first-page":"2137","article-title":"Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn","volume":"18","author":"Liu","year":"2012","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2015-307955-30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcjo.2012.03.014","article-title":"A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis","volume":"47","author":"Kheirkhah","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archopht.1956.00930040059008","article-title":"The effect of cortisone on experimental pseudomonas corneal ulcers","volume":"56","author":"Suie","year":"1956","journal-title":"AMA Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-32","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.37.9.1856","article-title":"Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen","volume":"37","author":"Hobden","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307955-33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00003226-199209000-00007","article-title":"Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis","volume":"11","author":"Ohadi","year":"1992","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307955-34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.1985.01050050110028","article-title":"A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid","volume":"103","author":"Badenoch","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-35","first-page":"553","article-title":"Treatment of Pseudomonas keratitis in the rabbit with antibiotic-steroid combinations","volume":"16","author":"Bohigian","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00003226-199209000-00008","article-title":"Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model","volume":"11","author":"Gritz","year":"1992","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307955-37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archopht.1978.03910050082021","article-title":"Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy","volume":"96","author":"Davis","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-38","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0161-6420(99)90250-6","article-title":"Risk factors in microbial keratitis leading to penetrating keratoplasty","volume":"106","author":"Miedziak","year":"1999","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.47102\/annals-acadmedsg.V33N4p484","article-title":"Contact lens microbial keratitis and prior topical steroid use: a disaster in the making?","volume":"33","author":"Wang","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.1136\/bjophthalmol-2015-307955-40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10792-008-9206-6","article-title":"Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital","volume":"29","author":"Al-Shehri","year":"2009","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bjo.74.9.528","article-title":"Topical steroids in the treatment of central and paracentral corneal ulcers","volume":"74","author":"Carmichael","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3129\/i10-054","article-title":"Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial","volume":"46","author":"Blair","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bjo.2008.147298","article-title":"Corticosteroids for bacterial corneal ulcers","volume":"93","author":"Srinivasan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archophthalmol.2011.303","article-title":"The steroids for corneal ulcers trial: study design and baseline characteristics","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ajo.2012.06.001","article-title":"Nocardia keratitis: clinical course and effect of corticosteroids","volume":"154","author":"Lalitha","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2013.09.025","article-title":"The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial","volume":"157","author":"Srinivasan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jamaophthalmol.2014.292","article-title":"Early addition of topical corticosteroids in the treatment of bacterial keratitis","volume":"132","author":"Ray","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1167\/iovs.11-7840","article-title":"Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment","volume":"53","author":"Sy","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-50","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1167\/iovs.14-13980","article-title":"Visual outcomes in treated bacterial keratitis: four years of prospective follow-up","volume":"55","author":"McClintic","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00003226-199211000-00001","article-title":"Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model","volume":"11","author":"Paschal","year":"1992","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307955-52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1442-9071.2011.02679.x","article-title":"Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management","volume":"40","author":"Girgis","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-9394(71)90434-X","article-title":"Combined pimaricin and dexamethasone therapy of keratomycosis","volume":"71","author":"Newmark","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12126","article-title":"Mycotic keratitis: epidemiology, diagnosis and management","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307955-55","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1167\/iovs.02-1135","article-title":"Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis","volume":"44","author":"Schreiber","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-56","first-page":"331","article-title":"Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids","volume":"25","author":"O'Day","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0161-6420(97)30228-0","article-title":"Ulcerative keratitis in bullous keratopathy","volume":"104","author":"Luchs","year":"1997","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0039-6257(86)90077-9","article-title":"Corticosteroid-induced cataracts","volume":"31","author":"Urban","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract","volume":"23","author":"James","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-307955-60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: a review of the literature","volume":"20","author":"Kersey","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2015-307955-61","unstructured":"PRED FORTE\u00ae (prednisolone acetate ophthalmic suspension, USP) 1%. http:\/\/dailymed.nlm.nih.gov\/dailymed\/archives\/fdaDrugInfo.cfm?archiveid=42364 (accessed 29 Sep 2015)."},{"key":"key-10.1136\/bjophthalmol-2015-307955-62","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jcrs.2010.08.026","article-title":"Corneal\/scleral thinning and corticosteroids","volume":"36","author":"Mackool","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2015-307955-63","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-64","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.ophtha.2013.08.026","article-title":"The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the cornea donor study","volume":"120","author":"Mannis","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-65","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-66","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","article-title":"Long-term graft survival after penetrating keratoplasty","volume":"110","author":"Thompson","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-67","volume-title":"Cochrane database of systematic reviews","author":"De Silva","year":"1996"},{"key":"key-10.1136\/bjophthalmol-2015-307955-68","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","article-title":"Ocular complications of pediatric uveitis","volume":"111","author":"Rosenberg","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-69","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ophtha.2014.05.021","article-title":"Periocular corticosteroid injections in uveitis: effects and complications","volume":"121","author":"Sen","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-70","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2014.10.013","article-title":"Uveitis in Beh\u00e7et disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group","volume":"159","author":"Arevalo","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09273948.2015.1025984","article-title":"Clinical outcomes of patients with vogt-koyanagi-harada disease over 12 years at a tertiary center","author":"Arevalo","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2015-307955-73","first-page":"245","article-title":"The unfavorable effect of topical steroid therapy on herpetic keratitis","volume":"58","author":"Thygeson","year":"1960","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.1136\/bjophthalmol-2015-307955-74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2415-3-10","article-title":"Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea","volume":"3","author":"Reviglio","year":"2003","journal-title":"BMC Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307955-75","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-76","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2012.11.013","article-title":"Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers","volume":"120","author":"Sharma","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-77","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-78","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/bjophthalmol-2013-304660","article-title":"Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials","volume":"98","author":"McDonald","year":"2014","journal-title":"Br J Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307955-79","first-page":"1381","article-title":"Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis","volume-title":"Clin Infect Dis","author":"Lalitha","year":"2012"},{"key":"key-10.1136\/bjophthalmol-2015-307955-80","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1167\/iovs.12-11246","article-title":"Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis","volume":"54","author":"Oldenburg","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307955-81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0000000000000581","article-title":"Post hoc analyses: after the facts","volume":"99","author":"Srinivas","year":"2015","journal-title":"Transplantation"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-307955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:57:33Z","timestamp":1718301453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-307955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":81,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,20]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1136\/bjophthalmol-2015-307955"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307955","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}